{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:15:36Z","timestamp":1793110536039,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","obstetanesthesia.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Obstetric Anesthesia"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ijoa.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T03:46:56Z","timestamp":1538020016000},"page":"73-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Obstetric anesthesia management of the patient with cardiac disease"],"prefix":"10.1016","volume":"37","author":[{"given":"K.W.","family":"Arendt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.J.","family":"Lindley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijoa.2018.09.011_b0005","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC Guidelines on the management of cardiovascular diseases during pregnancy; The task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC)","volume":"32","author":"Regitz-Zagrosek","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijoa.2018.09.011_b0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11886-005-0053-z","article-title":"Pregnancy in women with congenital heart disease","volume":"7","author":"Connolly","year":"2005","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.ijoa.2018.09.011_b0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011\u20132013","volume":"130","author":"Creanga","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/AOG.0000000000000564","article-title":"Pregnancy-related mortality in the United States, 2006\u20132010","volume":"125","author":"Creanga","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0025","series-title":"Kurinczuk JJ, on behalf of MBBRACE-UK. Saving lives, improving mothers' care \u2013 lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2013\u20132015","first-page":"24","author":"Knight","year":"2017"},{"key":"10.1016\/j.ijoa.2018.09.011_b0030","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1161\/CIR.0000000000000458","article-title":"Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association","volume":"135","author":"Canobbio","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijoa.2018.09.011_b0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehs270","article-title":"Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology","volume":"34","author":"Roos-Hesselink","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijoa.2018.09.011_b0040","first-page":"e714","article-title":"ACC\/AHA 2008 Guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"118","author":"Warnes","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijoa.2018.09.011_b0045","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/hrt.2006.095240","article-title":"Risks of contraception and pregnancy in heart disease","volume":"92","author":"Thorne","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ijoa.2018.09.011_b0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11936-015-0413-y","article-title":"Contraception and pregnancy planning in women with congenital heart disease","volume":"17","author":"Lindley","year":"2015","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.ijoa.2018.09.011_b0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/hc3001.093437","article-title":"Prospective multicenter study of pregnancy outcomes in women with heart disease","volume":"104","author":"Siu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijoa.2018.09.011_b0060","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/eurheartj\/ehq200","article-title":"Predictors of pregnancy complications in women with congenital heart disease","volume":"31","author":"Drenthen","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijoa.2018.09.011_b0065","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.jacc.2018.02.076","article-title":"Pregnancy outcomes in women with heart disease: the CARPREG II study","volume":"71","author":"Silversides","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0070","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/heartjnl-2014-305597","article-title":"Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease","volume":"100","author":"Balci","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.ijoa.2018.09.011_b0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/eurheartj\/ehn597","article-title":"Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?","volume":"30","author":"Bedard","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijoa.2018.09.011_b0080","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1471-0528.2009.02492.x","article-title":"Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach","volume":"117","author":"Kiely","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.ijoa.2018.09.011_b0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1753465812461680","article-title":"Pulmonary arterial hypertension in pregnant women","volume":"7","author":"Safdar","year":"2013","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ijoa.2018.09.011_b0090","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.2146\/ajhp060391","article-title":"Treatment of pulmonary arterial hypertension in pregnancy","volume":"64","author":"Huang","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijoa.2018.09.011_b0095","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bpobgyn.2014.03.007","article-title":"Aorta pathology and pregnancy","volume":"28","author":"van Hagen","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/chd.12546","article-title":"Cardiovascular outcomes of pregnancy in Marfan\u2019s syndrome patients: a literature review","volume":"13","author":"Kim","year":"2018","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.ijoa.2018.09.011_b0105","doi-asserted-by":"crossref","unstructured":"Task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003;24:761\u201381.","DOI":"10.1016\/S0195-668X(03)00098-8"},{"key":"10.1016\/j.ijoa.2018.09.011_b0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ccl.2012.04.003","article-title":"Congenital heart disease in pregnancy","volume":"30","author":"Franklin","year":"2012","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.ijoa.2018.09.011_b0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2011.04.014","article-title":"Pregnancy in patients with pre-existing cardiomyopathies","volume":"58","author":"Stergiopoulos","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijgo.2009.10.011","article-title":"Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers","volume":"109","author":"Fett","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ijoa.2018.09.011_b0125","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJM200105243442101","article-title":"Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy","volume":"344","author":"Elkayam","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijoa.2018.09.011_b0130","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/ejhf.808","article-title":"Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy","volume":"19","author":"Hilfiker-Kleiner","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ijoa.2018.09.011_b0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccl.2012.04.007","article-title":"Cardiovascular drugs in pregnancy","volume":"30","author":"Frishman","year":"2012","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.ijoa.2018.09.011_b0140","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/OGX.0000000000000190","article-title":"Adult congenital heart disease in pregnancy","volume":"70","author":"Lindley","year":"2015","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ijoa.2018.09.011_b0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1586\/erc.09.179","article-title":"Pregnant women with congenital heart disease: cardiac, anesthetic and obstetrical implications","volume":"8","author":"Fernandes","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.ijoa.2018.09.011_b0150","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1213\/ANE.0b013e31821ad83e","article-title":"A case series of the anesthetic management of parturients with surgically repaired tetralogy of Fallot","volume":"113","author":"Arendt","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2018.09.011_b0155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4065\/79.4.577","article-title":"The Valsalva maneuver-3 centuries later","volume":"79","author":"Nishimura","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijoa.2018.09.011_b0160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0025-6196(12)61852-7","article-title":"The Valsalva maneuver and response revisited","volume":"61","author":"Nishimura","year":"1986","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijoa.2018.09.011_b0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9378(83)90076-5","article-title":"Maternal catecholamines decrease during labor after lumbar epidural anesthesia","volume":"147","author":"Shnider","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0170","first-page":"158","article-title":"Lumbar epidural analgesia to improve intervillous blood flow during labor in severe preeclampsia","volume":"59","author":"Jouppila","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0175","first-page":"20","article-title":"The effects of epidural anesthesia on the Doppler velocimetry of umbilical and uterine arteries in normal and hypertensive patients during active term labor","volume":"77","author":"Ramos-Santos","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0180","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2044.1989.tb11372.x","article-title":"Changes in cardiac output during epidural anaesthesia for caesarean section","volume":"44","author":"Robson","year":"1989","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ijoa.2018.09.011_b0185","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.295.6607.1169","article-title":"Cardiac output during labour","volume":"295","author":"Robson","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ijoa.2018.09.011_b0190","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1213\/ane.0b013e318184ec14","article-title":"A randomized trial of dural puncture epidural technique compared with the standard epidural technique for labor analgesia","volume":"107","author":"Cappiello","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2018.09.011_b0195","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1213\/ANE.0000000000001798","article-title":"Dural puncture epidural technique improves labor analgesia quality with fewer side effects compared with epidural and combined spinal epidural techniques: a randomized clinical trial","volume":"124","author":"Chau","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2018.09.011_b0200","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/bja\/aen352","article-title":"Conversion of epidural labour analgesia to anaesthesia for Caesarean section: a prospective study of the incidence and determinants of failure","volume":"102","author":"Halpern","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ijoa.2018.09.011_b0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1098-7339(06)80050-7","article-title":"Identification of the epidural space: Is loss of resistance to air a safe technique? A review of the complications related to the use of air","volume":"22","author":"Saberski","year":"1997","journal-title":"Reg Anesth"},{"key":"10.1016\/j.ijoa.2018.09.011_b0210","first-page":"152","article-title":"Epidural air injection assessed by transesophageal echocardiography","volume":"20","author":"Jaffe","year":"1995","journal-title":"Reg Anesth"},{"key":"10.1016\/j.ijoa.2018.09.011_b0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1399-6576.2009.02080.x","article-title":"Regional anaesthesia for a Caesarean section in women with cardiac disease: a prospective study","volume":"54","author":"Langesaeter","year":"2010","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.ijoa.2018.09.011_b0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/eog.11.79","article-title":"Cardiovascular alterations in the parturient undergoing cesarean delivery with neuraxial anesthesia","volume":"7","author":"Arendt","year":"2014","journal-title":"Exp Rev Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0225","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijoa.2005.01.001","article-title":"Low-dose sequential combined spinal-epidural: an anaesthetic technique for caesarean section in patients with significant cardiac disease","volume":"14","author":"Hamlyn","year":"2005","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.ijoa.2018.09.011_b0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijoa.2008.09.009","article-title":"Anaesthesia for caesarean section in women with complex cardiac disease: 34 cases using the Braun Spinocath spinal catheter","volume":"18","author":"Dresner","year":"2009","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.ijoa.2018.09.011_b0235","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.thromres.2008.12.005","article-title":"Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin","volume":"124","author":"Abildgaard","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.ijoa.2018.09.011_b0240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.160.2.191","article-title":"Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature","volume":"160","author":"Chan","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijoa.2018.09.011_b0245","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/AAP.0b013e3181c15dd0","article-title":"Executive summary: regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (Third Edition)","volume":"35","author":"Horlocker","year":"2010","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.ijoa.2018.09.011_b0250","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/EJA.0b013e32833f6f6f","article-title":"Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology","volume":"27","author":"Gogarten","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0255","first-page":"175","article-title":"Central neural blockade in patients with a drug-induced alteration of coagulation. Third edition of the Belgian Association for Regional Anaesthesia (BARA) guidelines","volume":"62","author":"Vandermeulen","year":"2011","journal-title":"Acta Anaesthesiol Belg"},{"key":"10.1016\/j.ijoa.2018.09.011_b0260","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1399-6576.2009.02089.x","article-title":"Nordic guidelines for neuraxial blocks in disturbed haemostasis from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine","volume":"54","author":"Breivik","year":"2010","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.ijoa.2018.09.011_b0265","first-page":"1","article-title":"SBA recommendations for regional anesthesia safety in patients taking anticoagulants","volume":"64","author":"Fonseca","year":"2014","journal-title":"Braz J Anesthesiol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AAP.0000000000000763","article-title":"Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (Fourth Edition)","volume":"43","author":"Horlocker","year":"2018","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.ijoa.2018.09.011_b0275","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1213\/ANE.0000000000002530","article-title":"The Society for Obstetric Anesthesia and Perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants","volume":"126","author":"Leffert","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2018.09.011_b0280","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00000542-200601000-00004","article-title":"Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery: a randomized, double-blind, controlled trial","volume":"104","author":"Ngan Kee","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijoa.2018.09.011_b0285","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1399-6576.2012.02723.x","article-title":"Maternal and foetal effects of remifentanil for general anaesthesia in parturients undergoing caesarean section: a systematic review and meta-analysis","volume":"57","author":"Heesen","year":"2013","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.ijoa.2018.09.011_b0290","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1054\/ijoa.2001.0910","article-title":"The use of remifentanil during general anaesthesia for caesarean delivery in two patients with severe heart dysfunction","volume":"11","author":"Wadsworth","year":"2002","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.ijoa.2018.09.011_b0295","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/BF03018976","article-title":"The use of remifentanil for cesarean section in a parturient with recurrent aortic coarctation","volume":"47","author":"Manullang","year":"2000","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.ijoa.2018.09.011_b0300","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijoa.2003.12.008","article-title":"General anaesthesia using remifentanil for caesarean section in parturients with critical aortic stenosis: a series of four cases","volume":"13","author":"Orme","year":"2004","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.ijoa.2018.09.011_b0305","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ccl.2012.05.004","article-title":"Physiologic changes during normal pregnancy and delivery","volume":"30","author":"Ouzounian","year":"2012","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.ijoa.2018.09.011_b0310","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cardfail.2009.03.008","article-title":"Clinical profile and predictors of complications in peripartum cardiomyopathy","volume":"15","author":"Goland","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.ijoa.2018.09.011_b0315","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/AOG.0000000000000480","article-title":"The maternal early warning criteria: a proposal from the national partnership for maternal safety","volume":"124","author":"Mhyre","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0320","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jacc.2010.02.076","article-title":"B-type natriuretic peptide in pregnant women with heart disease","volume":"56","author":"Tanous","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0325","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ajog.2004.12.006","article-title":"Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women","volume":"193","author":"Resnik","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0330","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/AOG.0b013e3181aef106","article-title":"ACOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0335","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/OGX.0000000000000215","article-title":"Interventions for intrauterine resuscitation in suspected fetal distress during term labor: a systematic review","volume":"70","author":"Bullens","year":"2015","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ijoa.2018.09.011_b0340","first-page":"385","article-title":"Case reports: angina pectoris as a complication of ritodrine hydrochloride therapy in premature labor","volume":"60","author":"Ying","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0345","first-page":"10S","article-title":"Unexpected cardiac pathology in pregnant women treated with beta-adrenergic agents (ritodrine)","volume":"61","author":"Ron-El","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0350","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijgo.2006.05.032","article-title":"Hemodynamic effects of oxytocin during cesarean delivery","volume":"95","author":"Langes\u00e6ter","year":"2006","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ijoa.2018.09.011_b0355","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/bja\/aep137","article-title":"Haemodynamic effects of repeated doses of oxytocin during caesarean delivery in healthy parturients","volume":"103","author":"Langesaeter","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ijoa.2018.09.011_b0360","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijoa.2008.03.003","article-title":"The hemodynamics of oxytocin and other vasoactive agents during neuraxial anesthesia for cesarean delivery: findings in six cases","volume":"17","author":"Archer","year":"2008","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.ijoa.2018.09.011_b0365","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/bja\/aen071","article-title":"Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during caesarean section","volume":"100","author":"Svanstr\u00f6m","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ijoa.2018.09.011_b0370","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2044.2003.30435.x","article-title":"Effect of the confidential enquiries into maternal deaths on the use of Syntocinon\u00ae at caesarean section in the UK","volume":"58","author":"Bolton","year":"2003","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ijoa.2018.09.011_b0375","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/cvr\/11.1.26","article-title":"Changes in the pattern of regional pulmonary blood flow after PGF2 infusion in pregnant women","volume":"11","author":"Secher","year":"1977","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijoa.2018.09.011_b0380","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1213\/00000539-198811000-00020","article-title":"Life-threatening effects of intravascular absorption of PGF2 alpha during therapeutic termination of pregnancy","volume":"67","author":"Partridge","year":"1988","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2018.09.011_b0385","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.0001-6349.2005.0058d.x","article-title":"Myocardial infarction and mortality caused by methylergonovine","volume":"84","author":"Lin","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ijoa.2018.09.011_b0390","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00016347809155884","article-title":"Haemodynamic effects of oxytocin (syntocinon) and methyl ergometrine (methergin) on the systemic and pulmonary circulations of pregnant anaesthetized women","volume":"57","author":"Secher","year":"1978","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ijoa.2018.09.011_b0395","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1213\/XAA.0000000000000152","article-title":"Cesarean delivery in a parturient with left ventricular noncompaction complicated by acute pulmonary hypertension after methylergonovine administration for postpartum hemorrhage","volume":"4","author":"Spitzer","year":"2015","journal-title":"A A Case Rep"},{"key":"10.1016\/j.ijoa.2018.09.011_b0400","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijgo.2016.01.025","article-title":"Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery","volume":"134","author":"Elbohoty","year":"2016","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ijoa.2018.09.011_b0405","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/AOG.0000000000001626","article-title":"Active management of the third stage of labor with a combination of oxytocin and misoprostol to prevent postpartum hemorrhage: a randomized controlled trial","volume":"128","author":"Quibel","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0410","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.amjcard.2005.11.041","article-title":"Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes","volume":"97","author":"Silversides","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijoa.2018.09.011_b0415","first-page":"e506","article-title":"2015 ACC\/AHA\/HRS Guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society","volume":"133","author":"Page","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ijoa.2018.09.011_b0420","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIR.0000000000000300","article-title":"Cardiac arrest in pregnancy: a scientific statement from the American Heart Association","volume":"132","author":"Jeejeebhoy","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijoa.2018.09.011_b0425","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1213\/ANE.0000000000000171","article-title":"The Society for Obstetric Anesthesia and Perinatology consensus statement on the management of cardiac arrest in pregnancy","volume":"118","author":"Lipman","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2018.09.011_b0430","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ajog.2015.07.019","article-title":"Challenging the 4- to 5-minute rule: from perimortem cesarean to resuscitative hysterotomy","volume":"213","author":"Rose","year":"2015","journal-title":"Am J Obstet Gynecol"}],"container-title":["International Journal of Obstetric Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959289X18300864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959289X18300864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T16:40:01Z","timestamp":1557938401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959289X18300864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":86,"alternative-id":["S0959289X18300864"],"URL":"https:\/\/doi.org\/10.1016\/j.ijoa.2018.09.011","relation":{},"ISSN":["0959-289X"],"issn-type":[{"value":"0959-289X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obstetric anesthesia management of the patient with cardiac disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Obstetric Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijoa.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}